Margaret James Koziel

Axcella Therapeutics

SCHOLARLY PAPERS

1

DOWNLOADS

93

SSRN CITATIONS

0

CROSSREF CITATIONS

0

Scholarly Papers (1)

1.

Efficacy and Tolerability of AXA1125 (Endogenous Metabolic Modulator) in Fatigue-Predominant Long COVID: A Randomized, Double-Blind, Controlled Study

Number of pages: 21 Posted: 14 Feb 2023
University of Oxford - Oxford Centre for Clinical Magnetic Resonance Research (OCMR), University of Oxford - Oxford Centre for Clinical Magnetic Resonance Research (OCMR), Axcella Therapeutics, Axcella Therapeutics, University of Oxford - Oxford Centre for Clinical Magnetic Resonance Research (OCMR), Axcella Therapeutics, Axcella Therapeutics, University College London - Division of Medicine, University of Oxford - Oxford Centre for Clinical Magnetic Resonance Research (OCMR), University of Oxford - Oxford Centre for Clinical Magnetic Resonance Research (OCMR) and University of Oxford - Oxford Centre for Clinical Magnetic Resonance Research (OCMR)
Downloads 93 (534,335)

Abstract:

Loading...

Long COVID, mitochondrial dysfunction, magnetic resonance spectroscopy, therapy